A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys
- PMID: 8794335
- PMCID: PMC190741
- DOI: 10.1128/JVI.70.10.6922-6928.1996
A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys
Abstract
The utility of the simian immunodeficiency virus of macaques (SIVmac) model of AIDS has been limited by the genetic divergence of the envelope glycoproteins of human immunodeficiency virus type 1 (HIV-1) and the SIVs. To develop a better AIDS animal model, we have been exploring the infection of rhesus monkeys with chimeric simian/human immunodeficiency viruses (SHIVs) composed of SIVmac239 expressing HIV-1 env and the associated auxiliary HIV-1 genes tat, vpu, and rev. SHIV-89.6, constructed with the HIV-1 env of a cytopathic, macrophage-tropic clone of a patient isolate of HIV-1 (89.6), was previously shown to replicate to a high degree in monkeys during primary infection. However, pathogenic consequences of chronic infection were not evident. We now show that after two serial in vivo passages by intravenous blood inoculation of naive rhesus monkeys, this SHIV (SHIV-89.6P) induced CD4 lymphopenia and an AIDS-like disease with wasting and opportunistic infections. Genetic and serologic evaluation indicated that the reisolated SHIV-89.6P expressed envelope glycoproteins that resembled those of HIV-1. When inoculated into naive rhesus monkeys, SHIV-89.6P caused persistent infection and CD4 lymphopenia. This chimeric virus expressing patient isolate HIV-1 envelope glycoproteins will be valuable as a challenge virus for evaluating HIV-1 envelope-based vaccines and for exploring the genetic determinants of HIV-1 pathogenicity.
Similar articles
-
An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys.J Virol. 1996 May;70(5):3198-206. doi: 10.1128/JVI.70.5.3198-3206.1996. J Virol. 1996. PMID: 8627800 Free PMC article.
-
Chronology of genetic changes in the vpu, env, and Nef genes of chimeric simian-human immunodeficiency virus (strain HXB2) during acquisition of virulence for pig-tailed macaques.Virology. 1998 Sep 1;248(2):275-83. doi: 10.1006/viro.1998.9300. Virology. 1998. PMID: 9721236
-
Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses.Virology. 1999 Mar 30;256(1):15-21. doi: 10.1006/viro.1999.9632. Virology. 1999. PMID: 10087222
-
Understanding the basis of CD4(+) T-cell depletion in macaques infected by a simian-human immunodeficiency virus.Vaccine. 2002 May 6;20(15):1934-7. doi: 10.1016/s0264-410x(02)00072-5. Vaccine. 2002. PMID: 11983249 Review.
-
Advances in simian--human immunodeficiency viruses for nonhuman primate studies of HIV prevention and cure.Curr Opin HIV AIDS. 2020 Sep;15(5):275-281. doi: 10.1097/COH.0000000000000645. Curr Opin HIV AIDS. 2020. PMID: 32769631 Review.
Cited by
-
Quantification system for the viral dynamics of a highly pathogenic simian/human immunodeficiency virus based on an in vitro experiment and a mathematical model.Retrovirology. 2012 Feb 25;9:18. doi: 10.1186/1742-4690-9-18. Retrovirology. 2012. PMID: 22364292 Free PMC article.
-
A species-specific amino acid difference in the macaque CD4 receptor restricts replication by global circulating HIV-1 variants representing viruses from recent infection.J Virol. 2012 Dec;86(23):12472-83. doi: 10.1128/JVI.02176-12. Epub 2012 Sep 12. J Virol. 2012. PMID: 22973036 Free PMC article.
-
Adaptation of the human immunodeficiency virus type 1 envelope glycoproteins to new world monkey receptors.J Virol. 2008 Jan;82(1):346-57. doi: 10.1128/JVI.01299-07. Epub 2007 Oct 24. J Virol. 2008. PMID: 17959679 Free PMC article.
-
Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3).J Virol. 2001 Feb;75(4):1990-5. doi: 10.1128/JVI.75.4.1990-1995.2001. J Virol. 2001. PMID: 11160699 Free PMC article.
-
Evidence for viral virulence as a predominant factor limiting human immunodeficiency virus vaccine efficacy.J Virol. 2000 May;74(9):4017-27. doi: 10.1128/jvi.74.9.4017-4027.2000. J Virol. 2000. PMID: 10756013 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials